Understanding the Current Rating
The 'Hold' rating assigned to National Peroxide Ltd indicates a cautious stance for investors. It suggests that while the stock may not be an immediate buy, it is not a sell either, reflecting a balanced view of the company’s prospects. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment and helps investors understand the stock’s potential risks and rewards.
Quality Assessment
As of 29 June 2026, National Peroxide Ltd’s quality grade is considered below average. This is primarily due to the company’s weak long-term fundamental strength, evidenced by a compound annual growth rate (CAGR) of -24.68% in operating profits over the past five years. Such a decline signals challenges in sustaining profitability and operational efficiency over the medium to long term. Additionally, the average Return on Equity (ROE) stands at a modest 2.63%, indicating limited profitability generated from shareholders’ funds. These factors collectively temper the company’s quality score and weigh on investor confidence.
Valuation Perspective
Despite the quality concerns, the valuation of National Peroxide Ltd remains attractive. The stock currently trades at a Price to Book (P/B) ratio of 0.9, which is below the average historical valuations of its peers in the commodity chemicals sector. This discount suggests that the market is pricing in some of the risks associated with the company’s fundamentals. However, it also presents a potential opportunity for value-oriented investors seeking exposure to a microcap stock with a relatively low entry price. The Price/Earnings to Growth (PEG) ratio is notably low at 0.1, reflecting the stock’s earnings growth relative to its price, which may appeal to investors looking for undervalued growth prospects.
Financial Trend and Recent Performance
The financial trend for National Peroxide Ltd is very positive as of 29 June 2026. The company has demonstrated a remarkable turnaround in profitability, with net profit growth of 333.33% reported in the quarter ending March 2026. This strong performance is supported by the highest quarterly net sales of ₹85.68 crores and a peak PBDIT of ₹14.88 crores, translating to an operating profit margin of 17.37%. Furthermore, the company has declared positive results for two consecutive quarters, signalling improving operational momentum. However, it is important to note that despite these gains, the stock has underperformed the broader market over the past year, delivering a negative return of -14.08% compared to the BSE500’s decline of -1.13%. This divergence highlights the market’s cautious stance amid the company’s mixed fundamentals.
Technical Outlook
From a technical standpoint, National Peroxide Ltd exhibits a mildly bullish trend. The stock’s recent price movements show resilience, with a three-month return of +53.83% and a six-month gain of +21.39%. However, short-term volatility is evident, as reflected in the one-day decline of -1.71% and a one-month drop of -2.42%. These fluctuations suggest that while the stock has upward momentum, investors should be mindful of potential price corrections. The technical grade supports the 'Hold' rating by indicating moderate positive momentum without strong conviction for a sustained rally.
Shareholding and Market Capitalisation
National Peroxide Ltd is classified as a microcap stock, with promoters holding the majority stake. This concentrated ownership structure can provide stability but may also limit liquidity and influence market perception. Investors should consider these factors when evaluating the stock’s risk profile and potential for price appreciation.
Only 1% make it here. This Large Cap from the Gems, Jewellery And Watches sector passed our rigorous filters with flying colors. Be among the first few to spot this gem!
- - Highest rated stock selection
- - Multi-parameter screening cleared
- - Large Cap quality pick
Implications for Investors
The 'Hold' rating for National Peroxide Ltd suggests that investors should maintain a neutral position on the stock at present. The company’s attractive valuation and recent positive financial trends offer some upside potential, but these are tempered by weak long-term fundamentals and modest profitability. Investors with a higher risk tolerance may consider the stock for its value attributes and improving quarterly results, while more conservative investors might prefer to wait for clearer signs of sustained quality improvement and stronger technical confirmation before increasing exposure.
Summary of Key Metrics as of 29 June 2026
To recap, the stock’s key metrics include a Mojo Score of 56.0, reflecting the 'Hold' grade, a net profit surge of 333.33% in the latest quarter, and a P/B ratio of 0.9 indicating valuation attractiveness. The stock’s one-year return of -14.08% contrasts with its positive profit growth, underscoring the market’s cautious stance. The technical outlook remains mildly bullish, supporting a watchful approach rather than aggressive buying or selling.
Conclusion
National Peroxide Ltd’s current 'Hold' rating by MarketsMOJO, last updated on 17 June 2026, reflects a balanced view of the company’s prospects as of 29 June 2026. Investors should weigh the company’s improving financial performance against its longer-term quality challenges and market underperformance. This rating encourages a measured approach, with attention to future quarterly results and market developments that could influence the stock’s trajectory.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
